In a latest study, we described the identification and the characterization of a whole new atypical opioid receptor with one of a kind negative regulatory Houses in the direction of opioid peptides.1 Our benefits showed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and https://harryq368roi7.loginblogin.com/profile